Page 74 - LIN_ASO_2026_web-file

NCH Rooney Heart Institute

Performs Florida’s First M3 Transcatheter

Mitral Valve Replacement

by Paul Hiltz,
Naples Comprehensive Health President & CEO
very medical first represents years opening the chest. The innovative docking system creates a stable
of preparation, collaboration and landing zone for the replacement valve and offers a new treatment
Ean unwavering commitment to pathway for patients who previously had few or no viable options.
advancing patient care. The NCH Rooney This achievement reinforces the NCH Rooney Heart Institute's
Heart Institute recently achieved another reputation as one of the nation's leading cardiovascular programs.
significant milestone by becoming the first The Institute is home to one of the nation's most experienced
hospital in Florida to perform the FDA- valve programs, bringing together experts in structural heart
approved SAPIEN M3 Transcatheter Mitral Valve Replacement intervention, advanced cardiac imaging and minimally invasive
(TMVR), expanding treatment options to patients with severe cardiac surgery led by renowned cardiothoracic surgeon Joseph
mitral valve disease. Lamelas, MD, to provide comprehensive care for patients with
The procedure was performed by the NCH structural heart complex valvular heart disease.
team led by Robert J. Cubeddu, MD, President and Brynne While advanced technology makes procedures like this possible,
and Bob Colletti Endowed Chair of the NCH Rooney Heart it is the coordination of highly specialized physicians, nurses
Institute, Dee Dee Wang, MD, Section Head of Cardiac and cardiovascular professionals that transforms innovation into
Imaging, Robert Pascotto, MD, Cardiothoracic Surgeon, and a exceptional patient care. This multidisciplinary approach is what
multidisciplinary team of interventional cardiologists, cardiac enables our teams to perform some of the most sophisticated
imaging specialists, anesthesiologists, surgeons, nurses and cardiovascular procedures available today.
cardiovascular professionals working collaboratively to deliver At NCH, we continue to invest in groundbreaking
highly specialized structural heart care. technologies, expand nationally recognized specialty programs
The SAPIEN M3 system provides a minimally invasive and attract world-class clinical talent to ensure our community
alternative for patients with symptomatic severe mitral has access to the highest level of care. This procedure is a powerful
regurgitation who are not candidates for surgery or other example of the innovation that defines NCH.
transcatheter repair options. The technology represents the The NCH Rooney Heart Institute offers a comprehensive range
first fully percutaneous transseptal transcatheter mitral valve of cardiovascular services, including advanced imaging, structural
replacement therapy approved by the U.S. Food and Drug heart interventions, electrophysiology, heart failure management,
Administration. cardiothoracic surgery, vascular care, and a forthcoming transplant
Unlike traditional open-heart surgery, the procedure is program.
performed through a catheter inserted through a vein in the leg, For more information, please visit NCHmd.org/cardiology.
allowing physicians to replace the diseased mitral valve without

74 www.LifeInNaples.net